Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease.
Lloyd K, Papoutsopoulou S, Smith E, Stegmaier P, Bergey F, Morris L, Kittner M, England H, Spiller D, White MHR, Duckworth CA, Campbell BJ, Poroikov V, Martins Dos Santos VAP, Kel A, Muller W, Pritchard DM, Probert C, Burkitt MD; SysmedIBD Consortium.
Lloyd K, et al. Among authors: england h.
Dis Model Mech. 2020 Nov 27;13(11):dmm044040. doi: 10.1242/dmm.044040.
Dis Model Mech. 2020.
PMID: 32958515
Free PMC article.